| A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer (NCT04917809) | Memorial Sloan Kettering Cancer Center | 2022-02-17 |
| Afatinib in Advanced Refractory Urothelial Cancer (NCT02122172) | University of Chicago | 2017-09-13 |
| Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer (NCT02252393) | Case Comprehensive Cancer Center | 2015-10-01 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer (NCT01639521) | University of Southern California | 2013-05-01 |
| Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder (NCT01382706) | University of Southern California | 2011-06-13 |
| Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery (NCT01108003) | Roswell Park Cancer Institute | 2010-04-01 |
| Pazopanib in Treating Patients With Metastatic Urothelial Cancer (NCT00471536) | National Cancer Institute (NCI) | 2008-08-01 |
| Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function (NCT00478361) | M.D. Anderson Cancer Center | 2007-04-01 |
| In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? (NCT03174912) | Ankara Training and Research Hospital | 2007-01-01 |
| VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00407485) | National Cancer Institute (NCI) | 2006-11-01 |
| Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium (NCT00112905) | National Cancer Institute (NCI) | 2005-10-01 |
| Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract (NCT00112671) | National Cancer Institute (NCI) | 2005-04-01 |
| Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma (NCT01828736) | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 2004-02-09 |
| Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma (NCT00072150) | National Cancer Institute (NCI) | 2003-10-01 |
| Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00004856) | National Cancer Institute (NCI) | 2002-07-01 |
| Decitabine in Treating Patients With Advanced Solid Tumors (NCT00030615) | National Cancer Institute (NCI) | 2001-12-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Celecoxib in Treating Patients With Bladder Cancer (NCT00006124) | National Cancer Institute (NCI) | 2000-06-01 |
| Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer (NCT00005831) | National Cancer Institute (NCI) | 2000-03-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Gene Therapy in Treating Patients With Advanced Bladder Cancer (NCT00003167) | National Cancer Institute (NCI) | 1998-05-01 |
| An Expanded Access Study of Bemarituzumab (FPA144) for a Single Patient With Recurrent Bladder Cancer (NCT03801278) | Five Prime Therapeutics, Inc. | |